Agilent Technologies, Inc. $A Shares Sold by RW Investment Management LLC

Key Points

• RW Investment Management LLC reduced its holdings in Agilent Technologies by 45.2%, selling 2,232 shares and ending the quarter with 2,710 shares valued at $317,000.
• The CEO, Padraig Mcdonnell, sold 1,508 shares at an average price of $117.44, resulting in a 3.87% decrease in his position.
• Agilent Technologies announced a quarterly dividend of $0.248 per share, representing an annualized yield of 0.8% with a payout ratio of 24.44%.

RW Investment Management LLC trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 45.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,710 shares of the medical research company's stock after selling 2,232 shares during the quarter. RW Investment Management LLC's holdings in Agilent Technologies were worth $317,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in A. Versor Investments LP acquired a new position in Agilent Technologies during the first quarter worth about $364,000. Corient IA LLC acquired a new position in Agilent Technologies during the first quarter worth about $292,000. Northwest & Ethical Investments L.P. grew its position in Agilent Technologies by 14.1% during the first quarter. Northwest & Ethical Investments L.P. now owns 385,655 shares of the medical research company's stock worth $45,114,000 after buying an additional 47,636 shares during the period. Raymond James Financial Inc. grew its position in Agilent Technologies by 2.8% during the first quarter. Raymond James Financial Inc. now owns 368,661 shares of the medical research company's stock worth $43,126,000 after buying an additional 10,077 shares during the period. Finally, Cresset Asset Management LLC grew its position in Agilent Technologies by 10.5% during the first quarter. Cresset Asset Management LLC now owns 9,300 shares of the medical research company's stock worth $1,088,000 after buying an additional 884 shares during the period.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Stock Performance

Shares of A stock opened at $119.30 on Monday. The company's fifty day simple moving average is $117.82 and its 200-day simple moving average is $118.08. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The company has a market cap of $33.89 billion, a PE ratio of 29.46, a P/E/G ratio of 3.62 and a beta of 1.22.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. During the same quarter in the previous year, the business posted $1.22 EPS. The firm's revenue was up 6.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st were issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, July 1st. Agilent Technologies's dividend payout ratio (DPR) is currently 24.44%.

Analysts Set New Price Targets

A has been the topic of several recent research reports. Barclays upped their price target on shares of Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a report on Tuesday, June 24th. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday, May 29th. Robert W. Baird reduced their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a report on Thursday, May 22nd. UBS Group reduced their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a report on Thursday, May 29th. Finally, Jefferies Financial Group reduced their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $139.77.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.